skip to Main Content

Parkinson’s Disease Drug Shows Anticancer Effects

Newsfeed image, light gray text on dark gray background
Research shows the Parkinson’s disease drug carbidopa displays significant anticancer effects in both human cell lines and mice when given at normal patient dosage levels.

This discovery, which is published in the Biochemical Journal, may explain the low incidence of many cancers (with the exception of melanoma) in patients with Parkinson’s disease and could lead the way to carbidopa being repurposed as an anticancer medication.  Read more . . .

Back To Top